Condition

Mycosis Fungoides clinical trials and research

• 14Clinical trials
• 5NIH research projects
• 9Countries

Newest Mycosis Fungoides clinical trials

All recruiting trials (14)

• Poteligeo (mogamulizumab) for adults with mycosis fungoides or Sézary syndrome

  This project will try Poteligeo (mogamulizumab) in adults with mycosis fungoides or Sézary syndrome who have had at least one prior systemic therapy to see how safe and effective it is in routine care in Korea.

  Recruiting at 5 sites Kyowa Kirin Co., Ltd. · Busan, Busan Metropolitan City and 5 other locations · NCT07132567

• Golidocitnib treatment for relapsed indolent T/NK-cell lymphomas

  This study is testing if a new oral medication called Golidocitnib can help people with relapsed indolent T/NK-cell lymphomas feel better after other treatments haven't worked.

  Recruiting Phase 2 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality and 1 other locations · NCT06716658

• Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues

  This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06580002

• Using a modified virus to treat patients with T-cell lymphoma

  This study is testing a modified virus combined with immunotherapy to see if it can safely treat patients with different types of T-cell lymphoma.

  Recruiting at 2 sites Phase 1 Mayo Clinic · Scottsdale, Arizona and 1 other locations · NCT06508463

• Long-term outcomes of juvenile-onset mycosis fungoides and lymphomatoid papulosis

  This study is looking at the long-term health of young people diagnosed with juvenile-onset mycosis fungoides and lymphomatoid papulosis to see how they are doing years later.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT06207812

• Registry for individuals with T-cell lymphoma

  This study is gathering information from people with T-cell lymphoma to help researchers learn more about the disease and improve treatments.

  Recruiting at 6 sites Memorial Sloan Kettering Cancer Center · Duarte, California and 25 other locations · NCT05978141

• Combining a topical treatment with radiation for skin lymphoma

  This study is testing if using a skin cream along with radiation can help patients with a type of skin lymphoma that hasn't improved with regular treatments.

  Recruiting Early Phase 1 Northwestern University · Chicago, Illinois · NCT05838599

• Using photopheresis to treat early-stage Mycosis Fungoides

  This study is testing if a light-based treatment called photopheresis can help people with early-stage Mycosis Fungoides, a type of skin lymphoma, feel better.

  Recruiting Phase 2 Columbia University · New York, New York · NCT05680558

• Combining low-dose radiation therapy with brentuximab vedotin for mycosis fungoides

  This study is testing if combining a low-dose radiation treatment with a medication called brentuximab vedotin can help people with mycosis fungoides, a type of skin lymphoma, feel better and improve their overall health.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT05357794

• Identifying biomarkers in patients with skin lymphomas.

  This study is trying to find specific markers in the blood and skin of people with skin lymphomas to see if they can help improve treatment options for patients with Mycosis Fungoides and Sézary Syndrome.

  Recruiting Lund University Hospital · Lund · NCT04904146

• Combining mogamulizumab with low-dose total skin electron beam therapy for treating skin lymphomas

  This study is testing if combining a new drug called mogamulizumab with a special type of skin radiation therapy can help people with certain skin lymphomas feel better.

  Recruiting Phase 2 Stanford University · Stanford, California · NCT04256018

• Testing a new treatment for relapsed T-cell non-Hodgkin lymphoma

  This study is testing a new treatment called ST-001 to see if it can help people with relapsed T-cell non-Hodgkin lymphoma feel better and have fewer side effects.

  Recruiting at 10 sites Phase 1 SciTech Development, Inc. · Scottsdale, Arizona and 9 other locations · NCT04234048

• Identifying Prognostic Factors in Mycosis Fungoides and Sezary Syndrome

  This study is trying to find out which factors can help predict survival for patients with advanced mycosis fungoides and Sezary syndrome to improve their care and outcomes.

  Recruiting at 13 sites Stanford University · Duarte, California and 12 other locations · NCT02848274

• Collection of blood, urine, and tissue samples for research on skin conditions

  This study is collecting blood, urine, and tissue samples from people with skin conditions like cutaneous T-cell lymphoma, eczema, and atopic dermatitis to help improve treatments in the future.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT00177268

NIH-funded research (5)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Understanding how skin cancer-associated fibroblasts affect immune detection in early mycosis fungoides

  This grant investigates how certain skin cells in early mycosis fungoides might help the cancer hide from the immune system, with findings aiming to improve future patient care.

  NIH research Beckman Research Institute/city of Hope · Duarte, United States · NIH-11617656

• Microbiome clues to better radiation response in a rare skin lymphoma

  Researchers are studying skin lymphoma CTCL to see how the gut and skin bacteria might influence how well radiation therapy works for patients.

  NIH research Emory University · Atlanta, United States · NIH-11391466

• Identifying a new marker for early diagnosis of a skin cancer called mycosis fungoides

  This study is looking at a specific marker in the skin cells of people with early-stage mycosis fungoides, a type of skin cancer, to help doctors find it more easily and provide better treatment for patients.

  NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11009055

• Visible-light activated hypericin ointment for mycosis fungoides

  A topical hypericin ointment activated by safe visible light aims to treat skin lesions in people with mycosis fungoides.

  NIH research University of Pennsylvania · Philadelphia, United States · NIH-11000756

• Understanding how certain cells in skin tumors affect immune response in mycosis fungoides

  This study is looking at how certain cells in the skin, called cancer-associated fibroblasts, behave in patients with early-stage mycosis fungoides, a type of skin lymphoma, to help us understand how they might affect the disease and find new ways to treat it.

  NIH research Johns Hopkins University · Baltimore, United States · NIH-10948591

Related topics

Quick answers

How many Mycosis Fungoides clinical trials are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in United States (11 trials), China (2 trials), Sweden (1 trial), Argentina (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →